Liver-specific Deletion of the NADPH-Cytochrome P450 Reductase Gene
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 54 of the 54 references it cites were found in a registry or an index.
Abstract
A mouse model with liver-specific deletion of the NADPH-cytochrome P450 reductase (Cpr) gene (designated Alb-Cre/Cprlox mice) was generated and characterized in this study. Hepatic microsomal CPR expression was significantly reduced at 3 weeks and was barely detectable at 2 months of age in the Alb-Cre+/-/Cprlox+/+ (homozygous) mice, with corresponding decreases in liver microsomal cytochrome P450 (CYP) and heme oxygenase (HO) activities, in pentobarbital clearance, and in total plasma cholesterol level. Nevertheless, the homozygous mice are fertile and are normal in gross appearance and growth rate. However, at 2 months, although not at 3 weeks, the homozygotes had significant increases in liver weight, accompanied by hepatic lipidosis and other pathologic changes. Intriguingly, total microsomal CYP content was increased in the homozygotes about 2-fold at 3 weeks and about 3-fold at 2 months of age; at 2 months, there were varying degrees of induction in protein (1-5-fold) and mRNA expression (0-67-fold) for all CYPs examined. There was also an induction of HO-1 protein (nearly 9-fold) but no induction of HO-2. These data indicate the absence of significant alternative redox partners for liver microsomal CYP and HO, provide in vivo evidence for the significance of hepatic CPR-dependent enzymes in cholesterol homeostasis and systemic drug clearance, and reveal novel regulatory pathways of CYP expression associated with altered cellular homeostasis. The Alb-Cre/Cprlox mouse represents a unique model for studying the in vivo function of hepatic HO and microsomal CYP-dependent pathways in the biotransformation of endogenous and xenobiotic compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore these animals had dramatically decreased capacities to metabolize acetaminophen, phenobarbital, and testosterone despite having a 5-fold increase in total hepatic P450 content.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [313]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“By contrast, liver-specific POR knockout mice created by cre/lox technology were grossly normal-developing, growing, and living as long as normal mice, and having normal reproductive capacity, indicating normal gonadal P450 function (312,313).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [313]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, these mice had hepatomegaly, accumulated hepatic lipids, and had a 99% decrease in bile acids, 65% decrease in serum cholesterol, and 50% decrease in serum triglycerides.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [313]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Liver-specific knockout of POR in mice decreases the activities of hepatic drug-metabolizing enzymes (312, 313), thereby potentially rendering some drugs teratogenic.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [313]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Carbon Monoxide-binding Pigment of Liver Microsomes
Omura, T., & Sato, R. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82244-3 · Cited by 11,781
P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature
Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199602000-00002 · Cited by 2,945
Cytochrome P-450: Structure, Mechanism, and Biochemistry
de Montellano, O., & Paul, R. (1986) · Medical Entomology and Zoology · Cited by 2,663
THE HEME OXYGENASE SYSTEM:A Regulator of Second Messenger Gases
Maines, M. D. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.517 · Cited by 2,505
Cytochrome P450: Structure, mechanism, and biochemistry
Pryor, W. A. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)83807-x · Cited by 1,598
Carbon Monoxide: a Putative Neural Messenger
Verma, A., Hirsch, D. J., Glatt, C. E., Ronnett, G. V., & Snyder, S. H. (1993) · Science · doi:10.1126/science.7678352 · Cited by 1,563
Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302
Immune System Impairment and Hepatic Fibrosis in Mice Lacking the Dioxin-Binding Ah Receptor
Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S. T., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1995) · Science · doi:10.1126/science.7732381 · Cited by 1,075
Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C., & Bradfield, C. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6731 · Cited by 891
Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms
Porter, T. D., & Coon, M. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92717-1 · Cited by 678
Research works printed but not linked: 7
- 4. Black, S. D., and Coon, M. J. (1987) Adv. Enzymol. Relat Areas Mol. Biol. 60, 35-87
- 13. Pluck, A. (1996) Int. J. Exp. Pathol. 77, 269 -278
- 15. Gu, J., Zhang, Q.-Y., Genter, M. B., Lipinskas, T. W., Negishi, M., Nebert, D. W., and Ding, X. (1998) J. Pharmacol. Exp. Ther. 285, 1287-1295
- 17. Su, T., Bao, Z. P., Zhang, Q.-Y., Smith, T. J., Hong, J. Y., and Ding, X. (2000) Cancer Res. 60, 5074 -5079
- 19. Ding, X., and Coon, M. J. (1990) Mol. Pharmacol. 37, 489 -496
- 23. Su, T., Sheng, J. J., Lipinskas, T. W., and Ding, X. (1996) Drug Metab. Dispos. 24, 884 -890
- 34. Maines, M. D. (2000) Cell Mol. Biol. 46, 573-585
Cited by
Items 101–200 of 215
Ge, Q., Guo, Y., Zheng, W., Cai, Y., Qi, X., & Zhao, S. (2021) · BMC Genomics · doi:10.1186/s12864-021-08044-9 · Cited by 40
“more, POR play an important role in heme catabolism, synthesis of steroid hormone and the activation of vitamin D [66].”
BackgroundThe Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Alqahtani, S., Bukhari, I. A., Albassam, A. A., & Alenazi, M. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1482277 · Cited by 31
Approaches to deorphanization of human and microbial cytochrome P450 enzymes
Guengerich, F. P., Tang, Z., Cheng, Q., & Salamanca-Pinzon, S. G. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.05.005 · Cited by 27
“[40], the physiological relevance has never been documented, and transgenic mice with very low NADPH-P450 reductase levels show very limited hepatic oxidation of drugs [41].”
BackgroundOverexpression of membrane proteins from higher eukaryotes in yeasts
Emmerstorfer‐Augustin, A., Wriessnegger, T., Hirz, M., & Pichler, H. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5948-4 · Cited by 28
“CYP450 activity is irrevocably linked to a finely balanced system of cofactor recycling, oxygen supply, correct integration of iron into the active site and perfect teamwork with the corresponding reductase that delivers electrons (Gu et al. 2003; Henderson et al. 2003; Omura 2010).”
Essential Role of the Cytochrome P450 Enzyme CYP2A5 in Olfactory Mucosal Toxicity of Naphthalene
Hu, J., Li, S., Li, L., Zhou, X. H., Xie, F., D’Agostino, J., Li, Y., & Ding, X. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054429 · Cited by 30
“Paraffin sections (4 mm) were stained with hematoxylin and eosin, for histopathological analysis (Gu et al., 2003, 2005).”
MethodSelf-citationWang, D., Wang, K., Sui, D., Ouyang, Z., Xu, H., & Wei, Y. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.02.019 · Cited by 26
Drug Interactions and the Pharmacist: Focus on Everolimus
Grabowsky, J. A. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r769 · Cited by 28
Xie, F., Zhou, X. H., Behr, M. J., Fang, C., Horii, Y., Gu, J., Kannan, K., & Ding, X. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.09.003 · Cited by 31
“Two knockout mouse models were utilized: the Cyp2a5-null mouse (Zhou et al., 2010) and the liver-Cprnull (LCN) mouse (Gu et al., 2003).”
InfluentialSelf-citationParween, S., Velazquez, M. N. R., Udhane, S. S., Kagawa, N., & Pandey, A. V. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01187 · Cited by 24
Gu, J., Chen, C.-S., Wei, Y., Fang, C., Xie, F., Kannan, K., Yang, W., Waxman, D. J., & Ding, X. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.118240 · Cited by 28
“Wadsworth Center, as described for the LCN mice (Gu et al., 2003).”
BackgroundMethodInfluentialSelf-citationLichtenstein, D., Mentz, A., Schmidt, F. F., Luckert, C., Buhrke, T., Marx‐Stoelting, P., Kalinowski, J., Albaum, S. P., Joos, T. O., Poetz, O., et al. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111690 · Cited by 26
New insights into the role of cytochrome P450 reductase (POR) in microsomal redox biology
Porter, T. D. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.02.002 · Cited by 24
Li, X., Zhang, C., Wang, K., & Lehmler, H. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115233 · Cited by 26
“Xinxin Ding (University of Arizona, AZ, USA) to establish a breeding colony at the University of Iowa (Gu et al., 2003; Wu et al., 2003).”
BackgroundInfluentialPorter, T. D., Banerjee, S., Stolarczyk, E. I., & Zou, L. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.038562 · Cited by 26
“This pattern of lipidosis closely resembles that observed in hepatocytes of hepatic POR-null mice (Gu et al., 2003; Henderson et al., 2003).”
BackgroundInhibitory effects of curculigoside on human liver cytochrome P450 enzymes
Lang, J. C. T., Li, W., Zhao, J., Wang, K., & Chen, D. (2016) · Xenobiotica · doi:10.1080/00498254.2016.1257171 · Cited by 22
“CYP1A2 plays an important role in drug metabolism and bioactivation of carcinogens (Gu et al., 2003; Zanger & Schwab, 2013).”
BackgroundFunctional POR A503V is associated with the risk of bladder cancer in a Chinese population
Xiao, X., Ma, G., Li, S., Wang, M., Liu, N., Ma, L., Zhang, Z., Chu, H., Zhang, Z., & Wang, S. (2015) · Scientific Reports · doi:10.1038/srep11751 · Cited by 23
Kim, E., Kim, E., Kwon, E., Jang, H.-S., Hur, C., & Choi, M. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2009.1350 · Cited by 22
Liu, S., Yao, Y., Lu, S., Aldous, K. M., Ding, X., Mei, C., & Gu, J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.05.022 · Cited by 21
“In recent years, conditional deletion of Cpr gene was achieved in several major organs in mice, including the liver (Gu et al., 2003), lung (Weng et al., 2007), intestine (Zhang et al., 2009), heart (Fang et al., 2008b), brain (Conroy et al., 2010) and mammary gland (Lin et al., 2012).”
InfluentialSelf-citationMa, L., Wu, Z., Wang, L., Zhang, X., Wang, J., Chen, C., Ni, X., Lin, Y., Cao, Y., Luan, Y., et al. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.157 · Cited by 22
Heintze, T., Klein, K., Hofmann, U., & Zanger, U. M. (2021) · Scientific Reports · doi:10.1038/s41598-020-79952-1 · Cited by 23
Turesky, R. J., Konorev, D., Fan, X., Tang, Y., Yao, L., Ding, X., Xie, F., Zhu, Y., & Zhang, Q.-Y. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00405 · Cited by 21
Self-citationModulation of Gene Expression in Liver of Hibernating Asiatic Toads (Bufo gargarizans)
Jin, L., Yu, J. P., Yang, Z. J., Merilä, J., & Liao, W. B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082363 · Cited by 20
“This enzyme takes part in an extra-hepatic P450 electron transport pathway and contributes to the accumulation of hepatic lipids [25,26].”
BackgroundDing, L., Li, L., Liu, S., Bao, X., Dickman, K. G., Sell, S., Mei, C., Zhang, Q.-Y., Gu, J., & Ding, X. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz225 · Cited by 21
“, 2013), liver-Cpr-null (Gu et al., 2003), IE-Cpr-null (Zhang et al.”
Self-citationComplete correction of murine phenylketonuria by selection-enhanced hepatocyte transplantation
Vonada, A., Wakefield, L., Martinez, M., Harding, C. O., Grompe, M., & Tiyaboonchai, A. (2023) · Hepatology · doi:10.1097/hep.0000000000000631 · Cited by 20
“Mice with a complete hepatic deficiency of Cypor [22,23] have been shown to develop and reproduce normally.”
BackgroundNovel SNPs in Cytochrome P450 Oxidoreductase
Hart, S. N., Li, Y., Nakamoto, K., Wesselman, C., & Zhong, X. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.322 · Cited by 20
Lü, H., Lei, X., Guo, S., Winkler, R., John, S., Kumar, D., Li, W., & Alnouti, Y. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01654-6 · Cited by 20
“mice have a ~50% decrease in Por activity [59], suggesting decreased POR activity in HET mice.”
BackgroundGonzález-Lopez, M., Sealls, W., Jesch, E. D., Brosnan, M. J., Ladunga, I., Ding, X., Black, P. N., & Dirusso, C. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00209.2010 · Cited by 21
“Livers of LCN mice are steatotic when mice are reared on standard rodent chow (13, 16).”
InfluentialSelf-citationHeintze, T., Wilhelm, D., Schmidlin, T., Hofmann, U., Zanger, U. M., Schwab, M. G., & Klein, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.769703 · Cited by 19
“Alterations in PPARα target gene expression may be causative to a decrease in fatty acid oxidation but an increase in fatty acid uptake, which subsequently accounts for the severe hepatic lipidosis observed in mice and cell culture experiments (Gu et al., 2003; Henderson et al., 2003;Weng et al., 2005; Porter et al.,…”
BackgroundInfluentialLi, L., & Porter, T. D. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.02.010 · Cited by 19
“with the hepatic lipidosis characteristic of these mice [11,12].”
BackgroundLv, J., Hu, L., Zhuo, W., Zhang, C., Zhou, H., & Fan, L. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000190 · Cited by 19
Hepatic cytochrome P450 ubiquitination: Conformational phosphodegrons for E2/E3 recognition?
Correia, M. A., Wang, Y., Kim, S.-M., & Guan, S. (2014) · IUBMB Life · doi:10.1002/iub.1247 · Cited by 20
“Furthermore, conditional deletion of the liver CPR gene in mice also elevates their constitutive hepatic CYP3A content (38, 39), plausibly due to reduced futile oxidative cycling and consequent protein stabilization.”
BackgroundWei, Y., Zhou, X., Fang, C., Li, L., Kluetzman, K., Yang, W., Zhang, Q.-Y., & Ding, X. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167411 · Cited by 17
“It is noteworthy that liver-Cpr-null models (Gu et al., 2003; Henderson et al., 2003) have been used for deducing whether extrahepatic organs play any substantial role in xenobiotic metabolism in vivo (e.”
BackgroundMethodSelf-citationHenderson, C. J., McLaughlin, L. A., Osuna‐Cabello, M., Taylor, M., Gilbert, I. H., McLaren, A. W., & Wolf, C. R. (2014) · Biochemical Journal · doi:10.1042/bj20140582 · Cited by 15
Wu, X., Zhai, G., Schnoor, J. L., & Lehmler, H. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00255 · Cited by 16
Li, X., Wu, X., Kelly, K. M., Veng‐Pedersen, P., & Lehmler, H. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00389 · Cited by 17
Potential Biological Functions of Cytochrome P450 Reductase-dependent Enzymes in Small Intestine
D’Agostino, J., Ding, X., Zhang, P., Jia, K., Fang, C., Zhu, Y., Spink, D. C., & Zhang, Q.-Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.354274 · Cited by 16
“Of particular relevance are HOs, which also depend on POR for function (2, 6).”
BackgroundResultSelf-citationKovalchuk, N., Kelty, J. S., Li, L., Hartog, M. A., Zhang, Q.-Y., Edwards, P., Winkle, L. S. V., & Ding, X. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.05.015 · Cited by 15
“The LCN mice undergo tissue-specific deletion of the Cpr gene in all hepatocytes, which results in tissue-specific abolishment of microsomal P450 activities in the liver (Gu et al., 2003a).”
Self-citationLiu, X., Xue, X., Gong, L., Qi, X., Wu, Y., Xing, G., Luan, Y., Xiao, Y., Wu, X., Li, Y., et al. (2011) · Metabolomics · doi:10.1007/s11306-011-0385-1 · Cited by 15
“We adopted a well-developed model, the liver-specific cytochrome P450 reductase (CPR) knockout (KO) mouse (Gu et al. 2003; Henderson et al. 2003), in which the CPR gene encoding for the sole electron donor for all microsomal CYPs was deleted specifically in the liver, resulting in a loss of hepatic…”
MethodSelf-citationUehara, S., Iida, Y., Ida-Tanaka, M., Goto, M., Kawai, K., Yamamoto, M., Higuchi, Y., Ito, S., Takahashi, R., Kamimura, H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-19242-0 · Cited by 17
Liver-Specific γ-Glutamyl Carboxylase-Deficient Mice Display Bleeding Diathesis and Short Life Span
Azuma, K., Tsukui, T., Ikeda, K., Shiba, S., Nakagawa, K., Okano, T., Urano, T., Horie‐Inoue, K., Ouchi, Y., Ikawa, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088643 · Cited by 14
“5 embryos [18] and the full activity was exhibited at 2 months after birth [19].”
BackgroundMethodLiver lobe and strain differences in the activity of murine cytochrome P450 enzymes
Rudeck, J., Bert, B., Marx‐Stoelting, P., Schönfelder, G., & Vogl, S. (2018) · Toxicology · doi:10.1016/j.tox.2018.06.001 · Cited by 14
Arlt, V. M., Henderson, C. J., Wolf, C. R., Stiborová, M., & Phillips, D. H. (2014) · Toxicology Research · doi:10.1039/c4tx00116h · Cited by 14
Biochemical analysis of mutations in P450 oxidoreductase
Pandey, A. V. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341186 · Cited by 14
Zhu, Y., Ding, X., Fang, C., & Zhang, Q.-Y. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.088914 · Cited by 12
“The importance of hepatic and intestinal P450 enzymes to themaintenance of endogenous homeostasis and the protection against orally ingested xenobiotic compounds is illustrated by the compensatory increases in the expression of most xenobiotic metabolizing P450s, such as CYP2B, 2C, and 3A, in the organ (liver or SI) t…”
BackgroundResultInfluentialSelf-citationAssessing cytochrome P450 function using genetically engineered mouse models
Hannon, S. L., & Ding, X. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2022.05.008 · Cited by 11
Self-citationSelf-cleaving guide RNAs enable pharmacological selection of precise gene editing events in vivo
Tiyaboonchai, A., Vonada, A., Posey, J., Pelz, C., Wakefield, L., & Grompe, M. (2022) · Nature Communications · doi:10.1038/s41467-022-35097-5 · Cited by 13
Muroya, S., OTOMARU, K., Oshima, K., Oshima, I., Ojima, K., & Gotoh, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310682 · Cited by 17
Polusani, S. R., Kar, R., Riquelme, M. A., Masters, B. S. S., & Panda, S. P. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.132 · Cited by 14
“Although these mice grew normally and were fertile, they exhibited defective steroid and fatty acid metabolism and altered liver toxicity towards different drugs, which can be attributed to defects in CYPOR/CYP-mediated reactions [9,10].”
BackgroundOmeprazole Alleviates Aristolochia manshuriensis Kom-Induced Acute Nephrotoxicity
Wang, L., Zhang, H., Li, C., Yi, Y., Liu, J., Zhao, Y., Tian, J., Zhang, Y., Wei, X., Gao, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164215 · Cited by 11
Lee, C., Ding, X., & Riddick, D. S. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.048835 · Cited by 12
“These are novel findings with no clear mechanistic explanations currently, whereas the pronounced loss of POR mRNA, protein, and catalytic activity in LCN mice clearly confirmed the primary genetic alteration in this model (Gu et al., 2003).”
BackgroundMethodInfluentialSelf-citationLi, L., & Porter, T. D. (2009) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20299 · Cited by 11
Lee, C., Ding, X., & Riddick, D. S. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052993 · Cited by 10
“Despite the pronounced elevation of CYP3A11 mRNA and CYP3A protein, we confirmed that CYP3A catalytic activity is profoundly compromised in LCN mice due to loss of POR-dependent electron transfer to microsomal P450s, as reported previously for both LCN (Gu et al., 2003) and HRN (Henderson et al.”
Self-citationKovalchuk, N., Zhang, Q., Kelty, J. S., Winkle, L. S. V., & Ding, X. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.088930 · Cited by 10
“The hepatic deficit was modeled using LCN mice, which undergo tissue-specific deletion of the cytochrome P450 reductase (Cpr) gene in hepatocytes, resulting in tissue-specific ablation of nearly all microsomal P450 activity in the liver (Gu et al., 2003).”
BackgroundMethodResultSelf-citationVatsis, K. P., & Coon, M. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.167 · Cited by 10
Sundberg, C. D., & Hankinson, O. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz111 · Cited by 10
“Knockout of cytochrome P450 reductase in mice is lethal, whereas conditional knockout of Por in mouse liver has been shown to reduce activities of P450s (Gu et al. , 2003).”
BackgroundSelenium and/or iodine deficiency alters hepatic xenobiotic metabolizing enzyme activities in rats
Erkekoğlu, P., Giray, B., Çağlayan, A., & Hıncal, F. (2012) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2011.12.002 · Cited by 9
7-Dehydrocholesterol reductase activity is independent of cytochrome P450 reductase
Zou, L., Li, L., & Porter, T. D. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.06.011 · Cited by 9
“Indeed, the loss of POR expression severely impacts the activity of all known POR-dependent enzymes [7,11].”
BackgroundMethodInfluentialCheng, X., Gu, J., & Klaassen, C. D. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.060053 · Cited by 9
“2, the mRNA of some P450s, such as Cyp2b10, 3a11 and 4a14, which are hallmark target genes of CAR, PXR, and peroxisome proliferator-activated receptor a (PPARa) signaling, respectively, are markedly increased in livers of H-Cpr-null mice.”
BackgroundMethodSelf-citationHippocampal Expression of Cytochrome P450 1B1 in Penetrating Traumatic Brain Injury
Lidin, E., Sköld, M. K., Angéria, M., Davidsson, J., & Risling, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020722 · Cited by 9
P450 Oxidoreductase Deficiency (PORD)
Flück, C. E., & Pandey, A. V. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00010-7 · Cited by 11
In vivo expansion of gene-targeted hepatocytes through transient inhibition of an essential gene
Giorgi, M. D., Park, S. H., Castoreno, A. B., Cao, M., Hurley, A. E., Saxena, L., Chuecos, M. A., Walkey, C. J., Doerfler, A. M., Furgurson, M. N., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adk3920 · Cited by 11
Müller, G. D. A. E. S., Lüchmann, K. H., Razzera, G., Toledo‐Silva, G., Bebianno, M. J., Marques, M. R. F., & Bainy, A. C. D. (2018) · Aquatic Toxicology · doi:10.1016/j.aquatox.2018.06.001 · Cited by 8
Human P450 Oxidoreductase Deficiency
Flück, C. E., & Pandey, A. V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64966-8 · Cited by 12
In vivo selection of hepatocytes
Vonada, A., & Grompe, M. (2024) · Hepatology · doi:10.1097/hep.0000000000001143 · Cited by 9
Burke, R. S., Somasuntharam, I., Rearden, P., Brown, D., Deshmukh, S. V., DiPietro, M. A., DiMuzio, J. M., Eisenhandler, R., Fauty, S. E., Gibson, C. R., et al. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1433-0 · Cited by 7
Role of Lung P450 Oxidoreductase in Paraquat-Induced Collagen Deposition in the Lung
Kovalchuk, N., Jilek, J. L., Winkle, L. S. V., Cherrington, N. J., & Ding, X. (2022) · Antioxidants · doi:10.3390/antiox11020219 · Cited by 7
Self-citationZhu, Y., Xie, F., Ding, L., Fan, X., Ding, X., & Zhang, Q.-Y. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.223263 · Cited by 7
“CPR is essential for the activities of microsomal P450 enzymes as well as heme oxygenases (HO) (Gu et al., 2003).”
BackgroundSelf-citationCheng, X., Zhang, Y., & Klaassen, C. D. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.216796 · Cited by 7
“This is not surprising because the enzyme activity of Cpr is not completely diminished in livers of H-Cpr-null mice until 2 months after birth (Gu et al., 2003).”
BackgroundMethodResultInfluentialLuan, Y., Xing, G., Qi, X., Wu, M.-J., Li, C., Yao, J., Gong, L., Nohmi, T., Gu, J., Zhou, W., et al. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0891-6 · Cited by 7
Self-citationCytochrome b5 Binds Tightly to Several Human Cytochrome P450 Enzymes
Kim, D., Kim, V., Tateishi, Y., & Guengerich, F. P. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000475 · Cited by 7
Liu, W., Sui, D., Ye, H., Ouyang, Z., & Wei, Y. (2019) · PeerJ · doi:10.7717/peerj.6807 · Cited by 6
The First Defect in Electron Transfer to Mitochondrial P450 Enzymes
Miller, W. L., & Chung, B. (2016) · Endocrinology · doi:10.1210/en.2016-1044 · Cited by 5
CYP2D1 Gene Knockout Reduces the Metabolism and Efficacy of Venlafaxine in Rats
Zhou, H.-Q., Yang, L. C., Wang, C.-S., Li, Z., Ouyang, Z., Shan, M., Gu, J., & Wei, Y. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.088526 · Cited by 6
“Therefore, we used Ponceau S stain on the duplicate gel to guarantee the loading amount of protein per lane (5 μg/lane) was consistent (Gu et al., 2003).”
MethodSelf-citationDisorders of sterol biosynthesis
Furtado, L. V., Kelley, R. I., & Opitz, J. M. (2016) · Translational Science of Rare Diseases · doi:10.3233/trd-160004 · Cited by 6
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00096-4 · Cited by 6
Baptista, C., Esteves, F., Fallowfield, J. A., Kendall, T. J., Nelson, L. J., & Kranendonk, M. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01202-y · Cited by 8
Pleiotropy of Progesterone Receptor Membrane Component 1 in Modulation of Cytochrome P450 Activity
Barata, I. S., Rueff, J., Kranendonk, M., & Esteves, F. (2024) · Journal of Xenobiotics · doi:10.3390/jox14020034 · Cited by 8
“These hepatic CPR-null mice presented deregulated expression of more than two hundred genes crucial to hepatic homeostasis, including increased expression of hepatic drug-metabolizing CYPs and heme-oxygenase 1 (HO-1) [78,79].”
BackgroundYamazaki, K., Kubara, K., Sugahara, G., Muto, H., Yamamoto, M., Mano, Y., Mitsuhashi, K. O., Yamasaki, C., Ishida, Y., Tateno, C., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101466 · Cited by 6
“30 Notably, liver-specific KO of Por yields seemingly normal mice, 19,31,32 suggesting that lethality is due to a lack of electron transport to the extrahepatic P450 enzymes.”
Fang, C., Bolivar, V. J., Gu, J. H., Yang, W., Zeitlin, S. O., & Ding, X. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.027 · Cited by 4
“However, tissuespecific Cpr-null mouse models, such as brain-Cpr-null, liver-Cpr-null, lung-Cpr-null, cardiomyocyte-Cpr-null, and intestinal epithelium-Cpr-null (Conroy et al., 2010; Fang et al., 2008; Gu et al., 2003; Henderson et al., 2003; Weng et al., 2007; Zhang et al., 2009) are generally viable and thus suitabl…”
BackgroundInfluentialSelf-citationDiscrimination of haptens from prohaptens using the metabolically deficient Cprlow/low mouse
Chipinda, I., Blachère, F. M., Anderson, S. E., & Siegel, P. D. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.02.018 · Cited by 5
Panditi, V. R. (2013) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fi13080706 · Cited by 8
“The mechanism involves a variety of enzymes such as cytochrome P450 (CYP1, CYP2 and CYP3), that catalyze the oxidation and hydroxylation and NADPH-CYP reductase introducing reactive and polar groups into their substrates (williams, 1947; Liska, 1998; Danielson, 2002; Gu et al., 2003).”
BackgroundABSTRACTS FROM THE 10 TH INTERNATIONAL ISSX MEETING
(2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.868114 · Cited by 5
Clark, C., Pokhrel, M., Arthur, B., Suresh, P., Ates, I., Gibson, J., Dhungana, A., Mehlem, R., Boysia, A., Padalkar, M. V., et al. (2025) · Biology · doi:10.3390/biology14081091 · Cited by 3
“The histology and lipid results in the Ldlr − / − recipient mice selected with APAP are similar to the hepatic Cypor-null and Cypor-low mouse strains characterized in [39–41].”
A Novel POR G88S Mutation Causes Severe PORD and Establishes a Critical Pharmacogenomic Risk Profile
Velazquez, M. N. R., Dacal, J. L., Jørgensen, F. S., Sanguineti, N., Sharma, K., Marino, R. M., Garrido, N. P., Vaiani, E., Ramírez, P., Scaglia, P. A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf630 · Cited by 4
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00097-4 · Cited by 3
P450 oxidoreductase deficiency
Flück, C. E., Velazquez, M. N. R., & Pandey, A. V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00012-5 · Cited by 4
Lü, H., Lei, X., Guo, S., Winkler, R., John, S., Kumar, D., Li, W., & Alnouti, Y. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.06.427306 · Cited by 2
“Importantly, Por heterozygote mice have ~50% decrease in Por activity (44), suggesting decreased POR activity in heterozygote mice.”
BackgroundHenderson, C. J., Scheer, N., & Wolf, C. R. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2.2.105 · Cited by 1
Li, H., Li, S., Wang, Q., & Jia, C. (2016) · Human Genetics · doi:10.1007/s00439-016-1728-9 · Cited by 1
Jefcoate, C. R. E., & Larsen, M. C. (2008) · Springer eBooks · doi:10.1007/978-0-387-77300-1_14 · Cited by 1
Genetically Modified Mouse Models in ADME Studies
Jiang, X.-L., & Yu, A. (2012) · Wiley eBooks · doi:10.1002/9781118180778.ch28 · Cited by 1
Metabonomics in Understanding Drug Metabolism and Toxicology
Wen, B. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm079 · Cited by 1
Human Cytochrome P450 Metabolic Activation in Chemical Toxicity
Kim, D., & Chun, Y. (2007) · Toxicological Research · doi:10.5487/tr.2007.23.3.189 · Cited by 1
THE ROLE OF CONSTITUTIVE ANDROSTANE RECEPTOR AND ESTROGEN SULFOTRANSFERASE IN ENERGY HOMEOSTASIS
Gao, J. (2012) · D-Scholarship@Pitt (University of Pittsburgh)
Li, L. (2006) · UKnowledge (University of Kentucky)
Experimental Models of Drug Metabolism and Disposition
Luo, G., Lu, C., Ding, X., & Zhang, D. (2011) · Wiley eBooks · doi:10.1002/9780470929278.ch5
Self-citationNEW APPROACHES IN UNDERSTANDING DRUG METABOLISM
Hart, S. N. (2011) · KU ScholarWorks (University of Kansas)
Application of Humanised and Other Transgenic Models to Predict Human Responses to Drugs
Wolf, C. R., Kapelyukh, Y., Scheer, N., & Henderson, C. J. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622376-00152
Metadata
- Authors
- Gu, J., Weng, Y., Zhang, Q.-Y., Cui, H., Behr, M., Wu, L., Yang, W., Zhang, L., & Ding, X.
- Affiliations
- New York State Department of Health (US)
- Corresponding author
- Ding, Xinxin
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-07
- Volume
- 278
- Issue
- 28
- Pages
- 25895-25901
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1983773316
- Semantic Scholar
- e15f23ec26086915cba1a6a0a30d82a5ebee81de
- Cited by
- 214
- References
- 54
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 2 · 2023: 4 · 2022: 13 · 2021: 9 · 2020: 3 · 2019: 11 · 2018: 8 · 2017: 8 · 2016: 9 · 2015: 13 · 2014: 15 · 2013: 14 · 2012: 16
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6302 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (ES07462)
- National Institute of Environmental Health Sciences (R01ES007462, ES 07462)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- NADPH-cytochrome P450 reductase, liver-specific knockout, cytochrome P450 induction, heme oxygenase-1, heme oxygenase-2, hepatic lipidosis, cholesterol homeostasis, drug clearance, microsomal enzymes, biotransformation, liver microsomes
- MeSH terms
- Alleles, Animals, Body Weight, Cholesterol, Epoxide Hydrolases, Female, Genotype, Heme Oxygenase (Decyclizing), Homozygote, Liver, Male, Membrane Proteins, Mice, Transgenic, Microsomes, Liver, Models, Genetic, NADPH-Ferrihemoprotein Reductase, Organ Size, RNA, Sex Factors, Time Factors, Immunoblotting, Gene Expression Regulation, Enzymologic, Polymerase Chain Reaction, Gene Deletion, Mice, Heme Oxygenase-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.